{
  "version": "1.0.0",
  "training_date": "2024-12-15",
  "dataset": {
    "name": "ASZED-153",
    "source": "Data in Brief (DOI: 10.1016/j.dib.2025.111934)",
    "participants": {
      "total": 153,
      "schizophrenia": 77,
      "healthy_controls": 76
    },
    "channels": 16,
    "channel_layout": "10-20 system",
    "sampling_rate_hz": 250
  },
  "model": {
    "algorithm": "RandomForestClassifier",
    "feature_count": 264,
    "feature_types": [
      "spectral_power (80 features)",
      "erp_components (20 features)",
      "coherence (30 features)",
      "phase_lag_index (6 features)",
      "statistical (96 features)",
      "sample_entropy (16 features)",
      "fractal_dimension (16 features)"
    ],
    "hyperparameters": {
      "n_estimators": 100,
      "max_depth": null,
      "min_samples_split": 2,
      "min_samples_leaf": 1,
      "random_state": 42
    }
  },
  "performance": {
    "training_accuracy": 0.9375,
    "production_accuracy": 0.837,
    "evaluation_method": "subject-level cross-validation",
    "notes": "Production model retrained on ASZED-153 with correct channel montage"
  },
  "validation_status": {
    "internal_validation": "pending",
    "external_validation": "pending",
    "hardware_validation": "pending",
    "prospective_pilot": "pending"
  },
  "clinical_notes": {
    "intended_use": "Screening tool for schizophrenia risk assessment",
    "limitations": [
      "Single dataset (ASZED-153, Nigeria population)",
      "Binary classification only (schizophrenia vs. healthy control)",
      "Medication effects not accounted for",
      "No longitudinal data",
      "Hardware platform unvalidated"
    ],
    "disclaimer": "This is a screening tool only. Results should be interpreted by a qualified healthcare professional."
  }
}
